Cedric Francois

Insider Reports History

Entity: Individual
Location: 6400 Westwind Way, Suite A, Crestwood, KY
Signature: /s/ David Watson, attorney-in-fact for Cedric Francois
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cedric Francois:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Apellis Pharmaceuticals, Inc.	Chief Executive Officer, Director	Common Stock	533K	$15.7M	$29.52	Jan 29, 2025	Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2)
Apellis Pharmaceuticals, Inc.	Chief Executive Officer, Director	Common Stock	472K	$13.9M	$29.52	Jan 29, 2025	Indirect Owner (The Cedric Francois Irrevocable Trust of 2023)
Apellis Pharmaceuticals, Inc.	Chief Executive Officer, Director	Common Stock	416K	$12.3M	$29.52	Jan 29, 2025	Direct
Apellis Pharmaceuticals, Inc.	Chief Executive Officer, Director	Stock Option (Right to Buy)	176K	$11.6M	$66.30	Mar 1, 2024	Direct
Apellis Pharmaceuticals, Inc.	Chief Executive Officer, Director	Common Stock	300K	$8.86M	$29.52	Jan 29, 2025	Indirect Owner (The Francois Grossi Trust)
Apellis Pharmaceuticals, Inc.	Chief Executive Officer, Director	Common Stock	234K	$6.92M	$29.52	Jan 29, 2025	Indirect Owner (The Francois-DuBois Educational Trust)

Previous1Next

Showing 1 to 6 of 6 entries

Insider Reports Filed by Cedric Francois

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
APLS	Apellis Pharmaceuticals, Inc.	Jan 29, 2025	1	-$83.4K	4	Jan 30, 2025	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 22, 2025	1	-$412K	4	Jan 23, 2025	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 17, 2025	2	-$180K	4	Jan 21, 2025	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 13, 2025	1	-$179K	4	Jan 14, 2025	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Nov 1, 2024	1	$0	4	Nov 1, 2024	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Mar 1, 2024	9	-$15M	4	Mar 5, 2024	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Feb 12, 2024	1	-$268K	4	Feb 13, 2024	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 29, 2024	1	-$182K	4	Jan 31, 2024	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 22, 2024	1	-$873K	4	Jan 23, 2024	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 16, 2024	3	$6.43M	4	Jan 17, 2024	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Nov 21, 2023	1	-$244K	4	Nov 21, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Sep 19, 2023	2	$0	4	Sep 20, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Sep 1, 2023	4	-$5.46M	4	Sep 1, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	May 24, 2023	2	$0	4	May 25, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	May 16, 2023	10	-$2.44M	4	May 18, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Apr 27, 2023	2	$0	4	Apr 28, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Apr 18, 2023	5	-$2.33M	4	Apr 20, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Apr 3, 2023	6	$0	4	Apr 5, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Mar 21, 2023	9	-$1.27M	4	Mar 23, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Feb 27, 2023	2	$376K	4	Mar 1, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Feb 21, 2023	3	-$93.7K	4	Feb 22, 2023	Chief Executive Officer
APLS	Apellis Pharmaceuticals, Inc.	Feb 10, 2023	1	-$203K	4	Feb 14, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 27, 2023	1	-$152K	4	Jan 30, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 20, 2023	1	-$492K	4	Jan 24, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Apr 25, 2022	3	$6.9M	4	Jan 17, 2023	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Apr 25, 2022	9	-$1.24M	4	Dec 21, 2022	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Feb 10, 2022	1	-$119K	4	Feb 14, 2022	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 28, 2022	1	-$78.1K	4	Feb 1, 2022	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jan 21, 2022	2	$0	4	Jan 25, 2022	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Dec 31, 2021	1	$0	5	Feb 10, 2022	Chief Executive Officer, Director
APLS	Apellis Pharmaceuticals, Inc.	Jul 21, 2021	2	$62.1K	4	Jul 22, 2021	Chief Executive Officer, Director